A registry of acute myocardial infarction in Kuwait: Patients characteristics and practice patterns

Canadian Journal of Cardiology

Volumn 20, Issue 8, 2004, Pages 783-787

  Zubaid, Mohammad ^a   Rashed, Wafa A ^a   Husain, Mohammad ^b   Mohammad, Bader A ^b   Ridha, Mustafa ^c   Basharuthulla, Mahmood ^c   Rezq, Marwan Abu ^d   Smid, Jaroslav ^e   Thalib, Lukman ^b  

^a MUBARAK AL KABEER HOSPITAL   (Kuwait)

^b KUWAIT UNIVERSITY   (Kuwait)

^c AL ADAN HOSPITAL   (Kuwait)

^d AL AMIRI HOSPITAL   (Kuwait)

^e AL SABAH HOSPITAL   (Kuwait)

Author keywords

Coronary disease; Myocardial infarction; Registries

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTITHROMBOCYTIC AGENT; CARDIOVASCULAR AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY CARE UNIT; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; GENERAL HOSPITAL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KUWAIT; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORTALITY; PRESCRIPTION; PROSPECTIVE STUDY; REGISTER; RISK FACTOR; SMOKING; ST SEGMENT ELEVATION; CLINICAL PRACTICE; HEART INFARCTION; LENGTH OF STAY; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; STATISTICS; TREATMENT OUTCOME;

CARDIOVASCULAR AGENTS; CORONARY CARE UNITS; FEMALE; HOSPITAL MORTALITY; HUMANS; KUWAIT; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; PREVALENCE; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 3242771509     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
2. Yusuf S, Wittes J, Friedman L. Overview of results of randomised clinical trials in heart disease, I: Treatments following myocardial infarction. JAMA 1988;260:2088-93.
3. The Norwegian Multicentre Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-7.
4. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: Systematic overview of individual data from 100,000 patients in the randomized trials. Circulation 1998;97:2202-12.
5. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
6. European Secondary Prevention Study Group. Translation of clinical trials into practice: A European population based study of the use of thrombolysis for acute myocardial infarction. Lancet 1996;347:1203-7.
7. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez-Sendon J, for the GRACE Investigators. Practice variation and missed opportunities for reperfusion in ST-segment elevation myocardial infarction: Findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002;359:373-7.
8. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality in high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-97.
9. Barron HV, Bowlby AD, Breen T, et al. Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2. Circulation 1998;97:1150-6.
10. Barron HV, Michaels AD, Maynard C, Every NR. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2. J Am Coll Cardiol 1998;32:360-7.
11. Fonarow GC, French WJ, Parsons LS, Skin H, Malmgren JA. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 3. Circulation 2001; 103:38-44.
12. Health Kuwait, 32 edn. Health and Vital Statistics Division, Ministry of Health, Kuwait, 1995.
13. Rashed W, Zubaid M, David T, et al. Patient characteristics and practice patterns in the treatment of acute myocardial infarction in Kuwait: A pilot study. Med Principles Pract 2002;11:196-201.
14. Abdella N, Khogali M, AL-Ali S, Gumaa K, Bajaj J. Known type 2 diabetes mellitus among the Kuwaiti Population: A prevalence study. Acta Diabetol 1996;33:145-9.
15. Memon A, Moody PM, Sugathan TN, et al. Epidemiology of smoking among Kuwaiti adults: Prevalence, characteristics, and attitudes. Bull World Health Organ 2000;78:1306-15.
16. Husband DJ, Alberti KG, Julian DG. Stress hyperglycemia during acute myocardial infarction: An indicator of pre-existing diabetes? Lancet 1983;2:179-81.
17. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med 1994;331:1136-42.
18. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care, II: Adult advanced cardiac life Support. JAMA 1992;268:2199-241.
19. National Heart Attack Alert Program Coordinating Committee, 60 Minutes to Treatment Working Group. Emergency department: Rapid identification and treatment of patients with acute myocardial infarction. Ann Emerg Med 1994;23:311-29.
20. Sharkey SW, Brunette DD, Ruiz E, et al. An analysis of time delays preceding thrombolysis for acute myocardial infarction. JAMA 1989;262:3171-4.
21. Hirvonen TPJ, Halinen MO, Kala RA, Olkinuora JT, for the Finnish Hospitals' Thrombolysis Survey Group. Delays in thrombotytic therapy for acute myocardial infarction in Finland: Results of a national thrombolytic therapy delay study. Eur Heart J 1998;19:885-92.
22. Danchin N, Vaur L, Genes N, et al. Management of acute myocardial infarction in intensive care units in 1995: A nationwide French survey of practice and early hospital results. J Am Coll Cardiol 1997;30:1598-605.
23. McCormick D, Gurwitz JH, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Use of aspirin, beta-blockers and lipid lowering medications before recurrent acute myocardial infarction: Missed opportunities for prevention? Arch Intern Med 1999;159:561-7.